BiondVax Pharmaceuticals to Present at the First World Health Organization Meeting on Broadly Protective Influenza Vaccines on January 25th
1/15/2013 11:04:01 AM
More...
|
BiondVax Pharmaceuticals' Universal Influenza Vaccine M-001 Significantly Enhances the Efficacy of the Human Pandemic H5N1 Bird Flu Vaccine
12/17/2012 11:02:37 AM
More...
|
MonoSolRx LLC and BiondVax Pharmaceuticals Collaborate to Develop Oral Film Delivery of Flu Vaccine
11/7/2012 9:25:05 AM
More...
|
BiondVax Pharmaceuticals's Universal Flu Vaccine Improves Existing Flu Vaccines in Elderly. In a Second Phase II Trial, the Vaccine Proves Safe and Activates Immunity to Flu
2/16/2012 9:40:53 AM
More...
|
BiondVax Pharmaceuticals Announces Positive Phase IIa Results for Universal Flu Vaccine
6/16/2011 6:35:17 AM
More...
|
BiondVax Pharmaceuticals Begins Phase IIa Study for Universal Flu Vaccine
10/11/2010 6:44:39 AM
More...
|
Second Successful Phase I/II Clinical Trial for BiondVax Pharmaceuticals's Universal Flu Vaccine
4/28/2010 10:45:07 AM
More...
|
Successful Phase I/II Clinical Trial for BiondVax Pharmaceuticals' Universal Flu Vaccine
12/7/2009 9:39:48 AM
More...
|